(MedPage Today) — ORLANDO — A non-hormonal treatment for menopausal moderate-to-severe vasomotor symptoms that just nabbed FDA approval was safe and well-tolerated up to 1 year of treatment, according to a pooled-data analysis.
“It is my great…
Source link : https://www.medpagetoday.com/meetingcoverage/tms/118145
Author :
Publish date : 2025-10-25 21:56:00
Copyright for syndicated content belongs to the linked Source.
